EAST PROVIDENCE —IlluminOss Medical has received U.S. Food and Drug Administration de novo clearance – the first granted by the FDA’s Orthopedic Branch - for the IlluminOss Bone Stabilization System using light-sensitive resin for treatment of fractures of the humerus, radius and ulna from metastatic bone disease, a form of cancer. The East Providence-based, privately…
Want More Free?
To access 2 more articles, please log in or register for free.
Registered users get access to a limited number of free articles every month.